MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea
· Delayed Price · Currency is KRW 1,788.00
+32.00 (1.82%)
Apr 29, 2026, 3:30 PM KST
MYUNGMOON Pharm co.,Ltd Revenue
In the year 2025, MYUNGMOON Pharm co.,Ltd had annual revenue of 195.25B KRW with 4.72% growth. MYUNGMOON Pharm co.,Ltd had revenue of 50.75B in the quarter ending December 31, 2025, with 3.27% growth.
Revenue
195.25B
Revenue Growth
+4.72%
P/S Ratio
0.31
Revenue / Employee
670.95M
Employees
291
Market Cap
59.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 195.25B | 8.80B | 4.72% |
| Dec 31, 2024 | 186.44B | 16.88B | 9.95% |
| Dec 31, 2023 | 169.57B | 17.43B | 11.46% |
| Dec 31, 2022 | 152.13B | 14.38B | 10.43% |
| Dec 31, 2021 | 137.76B | 9.91B | 7.75% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Yuyu Pharma | 140.88B |
| Aprogen Biologics | 73.23B |
| Enzychem Lifesciences | 67.75B |
| Kukje Pharma | 175.50B |
| CKD Bio | 159.93B |
| Ildong Holdings | 590.89B |
| HANDOK | 535.14B |
| Jeil Pharma Holdings | 657.61B |